Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. The company offers machine vision products, which are used to automate the manufacturing and tracking of discrete items, such as mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. Its products include VisionPro, a software suite that provides various vision tools for programming; displacement sensors with vision software for use in 3D application; In-Sight vision systems that perform various vision tasks, including part location, identification, measurement, assembly verification, and robotic guidance; In-Sight vision sensors; ID products, including DataMan barcode readers and barcode verifiers, as well as vision-enabled mobile terminals for industrial barcode reading applications; and barcode scanning software development kits. The company sells its products to customers in the consumer electronics and automotive industries, and semiconductor and electronics capital equipment markets through direct sales force, as well as through a network of distributors and integrators. Cognex Corporation was founded in 1981 and is headquartered in Natick, Massachusetts.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorComputer and Technology
Current SymbolNASDAQ:CGNX
Previous Symbol
CUSIP19242210
Phone508-650-3000
Debt
Debt-to-Equity RatioN/A
Current Ratio7.18
Quick Ratio6.34
Price-To-Earnings
Trailing P/E Ratio28.86
Forward P/E Ratio34.88
P/E Growth2.3
Sales & Book Value
Annual Sales$747.95 million
Price / Sales9.63
Cash Flow$1.6177 per share
Price / Cash Flow25.87
Book Value$6.33 per share
Price / Book6.61
Profitability
EPS (Most Recent Fiscal Year)$1.45
Net Income$177.17 million
Net Margins18.52%
Return on Equity20.88%
Return on Assets17.82%
Miscellaneous
Employees1,771
Outstanding Shares172,190,000
Market Cap$7.13 billion
OptionableOptionable
Cognex (NASDAQ:CGNX) Frequently Asked Questions
What is Cognex's stock symbol?
Cognex trades on the NASDAQ under the ticker symbol "CGNX."
How often does Cognex pay dividends? What is the dividend yield for Cognex?
Cognex announced a quarterly dividend on Monday, October 29th. Stockholders of record on Friday, November 16th will be paid a dividend of $0.05 per share on Friday, November 30th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date of this dividend is Thursday, November 15th. This is an increase from Cognex's previous quarterly dividend of $0.05. View Cognex's Dividend History.
When did Cognex's stock split? How did Cognex's stock split work?
Shares of Cognex split before market open on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly minted shares were payable to shareholders after the market closes on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.
How will Cognex's stock buyback program work?
Cognex declared that its Board of Directors has authorized a stock buyback program on Monday, October 29th 2018, which allows the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to reacquire up to 2.8% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's board believes its shares are undervalued.
How were Cognex's earnings last quarter?
Cognex Co. (NASDAQ:CGNX) posted its quarterly earnings data on Monday, October, 29th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.37 by $0.08. The scientific and technical instruments company earned $232.22 million during the quarter, compared to the consensus estimate of $227.15 million. Cognex had a return on equity of 20.88% and a net margin of 18.52%. The firm's revenue for the quarter was down 12.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.14 earnings per share. View Cognex's Earnings History.
When is Cognex's next earnings date?
What guidance has Cognex issued on next quarter's earnings?
Cognex issued an update on its fourth quarter 2018 earnings guidance on Monday, October, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $180-190 million, compared to the consensus revenue estimate of $200.09 million.
What price target have analysts set for CGNX?
12 equities research analysts have issued 12 month price targets for Cognex's stock. Their forecasts range from $40.00 to $80.00. On average, they expect Cognex's share price to reach $51.2818 in the next year. This suggests a possible upside of 22.5% from the stock's current price. View Analyst Price Targets for Cognex.
What is the consensus analysts' recommendation for Cognex?
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 1 sell rating, 5 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cognex.
Has Cognex been receiving favorable news coverage?
Media coverage about CGNX stock has been trending very positive this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cognex earned a coverage optimism score of 3.6 on InfoTrie's scale. They also gave headlines about the scientific and technical instruments company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the immediate future.
Are investors shorting Cognex?
Cognex saw a decline in short interest in November. As of November 30th, there was short interest totalling 8,739,453 shares, a decline of 23.5% from the November 15th total of 11,419,412 shares. Based on an average daily trading volume, of 1,268,364 shares, the short-interest ratio is currently 6.9 days. Currently, 5.3% of the company's shares are short sold. View Cognex's Current Options Chain.
Who are some of Cognex's key competitors?
Some companies that are related to Cognex include Fortive (FTV), Keysight Technologies (KEYS), Sensata Technologies (ST), MKS Instruments (MKSI), Esterline Technologies (ESL), Orbotech (ORBK), Mesa Laboratories (MLAB), Rudolph Technologies (RTEC), Hurco Companies (HURC), Universal Detection Technology (UNDT), Clearsign Combustion (CLIR), Hickok (HICKA), International Isotopes (INIS), Sypris Solutions (SYPR) and Electro-Sensors (ELSE).
Who are Cognex's key executives?
Cognex's management team includes the folowing people:
- Mr. Robert J. Willett, CEO, Pres & Exec. Director (Age 50)
- Mr. John J. Curran, Sr. VP of Fin. & Admin., Treasurer and CFO (Age 52)
- Mr. Richard A. Morin, Sr. VP & Sec. (Age 68)
- Ms. Sheila DiPalma, Sr. VP of Corp. Employee Services & Corp. Officer (Age 51)
- Dr. Robert J. Shillman, Founder, Exec. Chairman & Chief Culture Officer (Age 71)
Who are Cognex's major shareholders?
Cognex's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.36%), Vanguard Group Inc. (8.58%), Bank of New York Mellon Corp (4.95%), Janus Henderson Group PLC (2.86%), Neuberger Berman Group LLC (2.07%) and Eagle Asset Management Inc. (1.91%). Company insiders that own Cognex stock include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Robert Willett and Theodor Krantz. View Institutional Ownership Trends for Cognex.
Which major investors are selling Cognex stock?
CGNX stock was sold by a variety of institutional investors in the last quarter, including Deutsche Bank AG, Pictet Asset Management Ltd., Renaissance Technologies LLC, FMR LLC, JPMorgan Chase & Co., JPMorgan Chase & Co., Mitsubishi UFJ Trust & Banking Corp and Pinnacle Associates Ltd.. Company insiders that have sold Cognex company stock in the last year include Anthony Sun and Jerry A Schneider. View Insider Buying and Selling for Cognex.
Which major investors are buying Cognex stock?
CGNX stock was purchased by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Standard Life Aberdeen plc, Standard Life Aberdeen plc, Bank of New York Mellon Corp, Nordea Investment Management AB, Riverbridge Partners LLC, DekaBank Deutsche Girozentrale and Neuberger Berman Group LLC. View Insider Buying and Selling for Cognex.
How do I buy shares of Cognex?
Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cognex's stock price today?
One share of CGNX stock can currently be purchased for approximately $41.85.
How big of a company is Cognex?
Cognex has a market capitalization of $7.13 billion and generates $747.95 million in revenue each year. The scientific and technical instruments company earns $177.17 million in net income (profit) each year or $1.45 on an earnings per share basis. Cognex employs 1,771 workers across the globe.
What is Cognex's official website?
How can I contact Cognex?
Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company can be reached via phone at 508-650-3000 or via email at [email protected]
MarketBeat Community Rating for Cognex (NASDAQ CGNX)
MarketBeat's community ratings are surveys of what our community members think about Cognex and other stocks. Vote "Outperform" if you believe CGNX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNX will underperform the S&P 500 over the long term. You may vote once every thirty days.
